# B-GLUCANCER2 : A Pilot Study Evaluating a New Method for Cancer Detection by Measuring the Activity of Different Glycosidase Enzymes in the Plasma of Patients With a Localized Cancer.

> **NCT07236177** · EARLY_PHASE1 · RECRUITING · sponsor: **Poitiers University Hospital** · enrollment: 220 (estimated)

## Conditions studied

- Breast Cancer
- Pancreatic Cancer
- Pulmonary Cancer
- Volatile Organic Compound
- Glycosidase Activity
- Probes
- Tumor Markers, Biological

## Interventions

- **BIOLOGICAL:** blood plasma sample
- **BIOLOGICAL:** blood sampling

## Key facts

- **NCT ID:** NCT07236177
- **Lead sponsor:** Poitiers University Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-03
- **Primary completion:** 2028-02-03
- **Final completion:** 2028-03-03
- **Target enrollment:** 220 (ESTIMATED)
- **Last updated:** 2026-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07236177

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07236177, "B-GLUCANCER2 : A Pilot Study Evaluating a New Method for Cancer Detection by Measuring the Activity of Different Glycosidase Enzymes in the Plasma of Patients With a Localized Cancer.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07236177. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*